The current valuation score of Ardelyx Inc is 9.28, ranking 41 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -21.86, which is -71.05% below the recent high of -6.33 and -346.46% above the recent low of -97.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.